Abstract:343 Objectives: Secondary injury persists after stroke onset, and deteriorates tissue and function outcomes in the long run. Peri-infarct depression (PID) is a validated pathological mechanism during secondary injury. As a depolarization wave spreading across the cortex, PID increases regional glucose demand and worsens supply-demand mismatch after stroke, thus expands infarct size. Peri-infarct depression emerges as a potential therapeutic target during stroke treatment. However, detection of PID with electrocorticography (ECoG) is invasive and has a restriction in further clinical practice. Taken metabolic challenge imposed by PID, we tend to monitor metabolic state of stroke brain by FDG PET imaging, and visualize metabolic stress induced by peri-infarct depression, thus provide a non-invasive method to monitor PID related injury. Method: Photochemical method is applied to induce a 1[asterisk]1mm infarction in rat cortex. After stroke, FDG PET imaging, ECoG recording, laser speckle imaging and rotarod test are performed daily for the first week, then weekly during the 2nd week to 4th week. Regional metabolic alteration is analyzed with SPM software. Immunohistochemical staining, western blot assay, and bioluminescence imaging are employed to assess metabolic state and mitochondria function. In vitro experiments on cortical neurons from embryonic day 18 rats are performed to investigate mechanism underlying metabolic change induced neuron dysfunction. Results: FDG PET imaging indicates growing regions with increased glucose uptake around infarct core during first week after stroke. The change in glucose uptake has no correlation with regional blood supply, while apparently affected by the occurrence of PID. Results of rotarod test demonstrate deteriorated neurological performance along with expanded metabolic change and increased incidents of PID. From the 2nd week after stroke, increased FDG uptake gradually decreases, and ends up with low uptake compared with healthy brain. Histological analysis indicates overall increased glycolysis, and reduced mitochondria function in brain regions with increased FDG uptake, where gliosis and increased microglia accumulation occur in chronic state. Regional metabolic alteration is mostly accompanied with overexpression of HIF1a. In vitro, 1uM DMOG is applied to elevate expression of HIF1a and induce the metabolic change in cultured neurons. With suppressed mitochondria function, neurons firstly exhibit increased intracellular calcium concentration, then neurite spines diminish and neurites degeneration. Administration of resveratrol in stroke rats at chronic phase of stroke or neurons treated with DMOG could efficiently increase mass and function of mitochondria, and improve tissue and functional consequence. Conclusion: FDG PET imaging is reliable to reflect metabolic stress imposed by peri-infarct depression. Peri-infarct depression leads to the metabolic change in neurons, including suppression of mitochondria function and overactivation of glycolysis, thus deteriorate functional and tissue consequence. The insults from PID could be alleviated by improving mitochondria function.

Regional brain glucose metabolism is differentially affected by ketogenic diet: a human semiquantitative positron emission tomography

Inverse relationship between brain glucose and ketone metabolism in adults during short-term moderate dietary ketosis: A dual tracer quantitative positron emission tomography study

Glucose Metabolic Profile by Visual Assessment Combined with Statistical Parametric Mapping Analysis in Pediatric Patients with Epilepsy.

Assessment of a one-week ketogenic diet on brain glycolytic metabolism and on the status epilepticus stage of a lithium–pilocarpine rat model

MRI spectroscopic and tractography studies indicate consequences of long-term ketogenic diet

Regional cerebral effects of ketone body infusion with 3-hydroxybutyrate in humans: Reduced glucose uptake, unchanged oxygen consumption and increased blood flow by positron emission tomography. A randomized, controlled trial

Nimg-80. Impact Of Ketogenic Diet On Molecular Metabolic Imaging With [18F]Fdg And [18F]Dasa-23 Positron Emission Tomography In A Patient With Glioblastoma

Brain Metabolic Characteristics Distinguishing Typical and Atypical Benign Epilepsy with Centro-Temporal Spikes.

[A study of microPET for assessing regional cerebral glucose metabolism and the expression of dopamine receptor type 2 in a rat model of Parkinson's disease].

FDG PET Imaging As A Non-invasive Method to Demonstrate Peri-infarct Depression after Stroke

[18F]FDG PET for mapping the cerebral glucose metabolic characteristics of drug-sensitive and drug-resistant epilepsy in pediatric patients

Nutritional Ketosis Increases NAD+/NADH Ratio in Healthy Human Brain: An in Vivo Study by 31P-MRS

Relationship of Ketosis With Myocardial Glucose Uptake Among Patients Undergoing FDG PET/CT for Evaluation of Cardiac Sarcoidosis

Ketogenic diet attenuates post-cardiac arrest brain injury by upregulation of pentose phosphate pathway–mediated antioxidant defense in a mouse model of cardiac arrest

Neuroprotection by the Ketogenic Diet: Evidence and Controversies

Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases

Functional FDG-PET: Measurement of Task Related Neural Activity in Humans—A Compartment Model Approach and Comparison to fMRI

A ketogenic diet modifies glutamate, gamma-aminobutyric acid and agmatine levels in the hippocampus of rats: A microdialysis study

Effects of the ketogenic diet on cognition: a systematic review

Effects of different carbohydrate diets on cardiac and brain uptake of 18F-FDG in Wistar rats

The Effect of the Ketogenic Diet on the Therapy of Neurodegenerative Diseases and Its Impact on Improving Cognitive Functions